ArticleCell cycle (Georgetown, Tex.)2012

Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).

Cristina Oliveras-Ferraros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.